Protocol I8F-MC-GPGN(a) The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes
Details
Age
Adult
Type of Study
Treatment
Locations
Highlands Ranch Hospital
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Neda Rasouli, MD
Study ID
Protocol Number: 20-0271
More information available at ClinicalTrials.gov: NCT04255433
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers